APP and Alzheimer disease: Investigations employing high-throughput sequencing comparing m6A RNA methylation in the brains of double-transgenic APP/PS1 with those of control mice revealed statistically significant elevations of m6A methyltransferase METTL3 and downregulations of m6A demethylase FTO in the cortex and hippocampus of AD mice [991].